Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Redwire | RDW | Apr 17, 2025 | 10.11 | +2.85 |
Redwood Trust | RWT | Apr 17, 2025 | 5.54 | +4.33 |
Redwood Trust | RWT-A | Apr 17, 2025 | 23.80 | +1.19 |
REE Automotive A | REE | Apr 17, 2025 | 2.51 | +2.87 |
Regal Rexnord | RRX | Apr 17, 2025 | 98.39 | +1.81 |
Regency Centers | REG | Apr 17, 2025 | 71.66 | +2.07 |
Regency Centers A Pref | REGCP | Apr 17, 2025 | 23.20 | +1.62 |
Regency Centers B Pref | REGCO | Apr 17, 2025 | 22.17 | -0.81 |
Regeneron Pharmaceuticals | REGN | Apr 17, 2025 | 563.16 | +2.53 |
REGENXBIO | RGNX | Apr 17, 2025 | 5.94 | -3.57 |
Regional Management | RM | Apr 17, 2025 | 31.27 | +0.61 |
Regions Financial | RF | Apr 17, 2025 | 19.31 | +0.73 |
Regions Financial C Pref | RF-C | Apr 17, 2025 | 22.30 | -0.36 |
Regions Financial E Pref | RF-E | Apr 17, 2025 | 16.79 | +0.67 |
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F | RF-F | Apr 17, 2025 | 24.59 | -0.24 |
Regis | RGS | Apr 17, 2025 | 16.99 | -3.90 |
Regulus Therapeutics | RGLS | Apr 17, 2025 | 2.06 | +6.19 |
Rein Therapeutics | RNTX | Apr 17, 2025 | 1.70 | 0.00 |
Reinsurance Group of America | RGA | Apr 17, 2025 | 184.71 | +1.15 |
REIT Index ETF Vanguard | VNQ | Apr 17, 2025 | 86.84 | +1.50 |
Reitar Logtech | RITR | Apr 17, 2025 | 4.18 | +3.21 |
Rekor Systems | REKR | Apr 17, 2025 | 0.83 | +9.80 |
Relay Therapeutics | RLAY | Apr 17, 2025 | 2.69 | +3.07 |
Reliance | RS | Apr 17, 2025 | 277.62 | +0.88 |
Reliance Global | RELI | Apr 17, 2025 | 1.01 | -0.98 |
Relmada Therapeutics | RLMD | Apr 17, 2025 | 0.29 | -0.75 |
RELX ADR | RELX | Apr 17, 2025 | 52.20 | +1.95 |
Remitly Global | RELY | Apr 17, 2025 | 19.93 | +0.45 |
Renaissance Ipo ETF | IPO | Apr 17, 2025 | 35.94 | +0.81 |
RenaissanceRe | RNR | Apr 17, 2025 | 240.65 | +1.18 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.